Clinical Trial Update: Zotarolimus-Versus Sirolimus-Versus PacliTaxel-Eluting Stent for Acute Myocardial Infarction Patients [Phase 4]

View source ↗

Summary

Phase 4 trial comparing zotarolimus-, sirolimus-, and paclitaxel-eluting stents in acute myocardial infarction was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Paclitaxel-eluting stent (paclitaxel-eluting stent)
• Sirolimus-eluting stent (sirolimus-eluting stent)
• Zotarolimus-eluting stent (zotarolimus)

Snippet

Sponsor: Seung-Jung Park | Conditions: Myocardial Infarction | Phase 4 | Status: TERMINATED